IgM antibody to hepatitis B core antigen (IgM anti-HBc) was determined in 60 patients whose serum was positive for hepatitis B surface antigen (HBsAg) and 18 patients whose serum was negative for HBsAg, but positive for antibody to hepatitis B core antigen (anti-HBc). Two radioimmunoassap were done
The detection in urine specimens of IgG and IgM antibodies to hepatitis A and hepatitis B core antigens
✍ Scribed by Mr. Keith R. Perry; John V. Parry; Elise M. Vandervelde; Philip P. Mortimer
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 545 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The use of urine as a noninvasive specimen for the diagnosis of hepatitis A (HAV) and hepatitis B (HBV) virus infections was investigated. Specimens of urine were collected at the same time as blood or saliva specimens, or singly in cases of previously serologically confirmed recent infection. The specimens were tested for IgG and IgM anti‐HAV and anti‐HBc by immunoglobulin class‐specific capture radioimmunoassays (GACRIA and MACRIA). On the basis of assays on urine specimens it was possible to distinguish between individuals who were susceptible or immune to HAV or who had recently been infected with HAV. Using assays on 327 corresponding saliva specimens as reference tests, the observed sensitivity and specificity of tests on urine specimens by anti‐HAV GACRIA were 98.9% and 99.1%, respectively, and by anti‐HAV MACRIA were 95.8% and 99.6%, respectively. IgM and IgG anti‐HBc were detected readily in the urine of 35 acute or recent cases of hepatitis B but were not found in the urine of seronegative individuals. Of the urine specimens from 52 individuals who were HBsAg carriers or who had had long past HBV infections, 49 contained detectable IgG anti‐HBc. Of urine specimens from 42 HBsAg carriers, 11 contained raised IgM anti‐HBc levels.
Urine, which is a convenient specimen to collect, can be used t o study outbreaks of hepatitis A, to ascertain the HAV immune status of individuals, to differentiate hepatitis A from hepatitis B, and to identify individuals who have been naturally exposed to HBV. © 1992 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Little is known about the immunoglobulin class of antibodies to HBcAg. In the present study sera containing anti-HBc were fractionated by surcose density-gradient centrifugation, and all serum fractions were tested against HBcAg by immunoelectro-osmophoresis. In addition selected fractions were exam
Antibody directed against HBsAg carries idiotypic determinants that may induce an autoantiidiotype antibody response. We describe a solid-phase radioimmunoassay which allows specific detection of either IgG or IgM antibody to antibody directed against HBsAg. Among 138 chronic hepatitis B virus carri
## Abstract A solid‐phase radioimmunoassay (RIA) for IgM anti‐HBc is described. The assay (anti‐m̈ RIA) is based on the adsorption of IgM to a tube coated with sheep antibody to the human IgM m̈‐chain. The adsorbed immunoglobulin is assayed for anti‐HBc activity. Positive reactions in the test are
## Abstract The IgG subclasses IgM and IgA1 of antibodies to hepatitis B core antigen (anti‐HBc) and hepatitis B e antigen (anti‐HBe) were assayed in sera from 82 patients with chronic hepatitis B utilising class/subclass‐specific enzyme immunoassays (EIA). The solid‐phase was either recombinant he
IgM antibody against core antigen of the hepatitis B virus (anti-HBc IgM) was selectively determined by a new enzyme immunoassay (EIA). Microtiter plates were coated with anti-human micro chain immunoglobulin. On addition of serum IgM is bound by a factor of about 4,000 more than IgG. After removing